Drug & Supplement Interactions

Fo-ti + Repotrectinib

Brand name of Repotrectinib

  • Augtyro

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Theoretically, fo-ti might increase the risk of liver damage when taken with hepatotoxic drugs. Of the 2 interaction records for this pair, the most serious is rated moderate.

This also applies to Augtyro, a brand name of repotrectinib.

Read the Full Interaction Report Dr. Brian Staiger, PharmD, Explains What This Interaction Means for You Why it happens, what you might notice and what to do, in plain words.1-minute read
Moderate
Possible
2
D

Ask a Question About This Combination

Ask in your own words about taking Fo-ti with Repotrectinib. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Fo-ti and Repotrectinib Interaction

2 interaction records apply to these two. Each one is explained separately below.

Why Are There 2 Interaction Records?

We file Fo-ti’s interactions under single medicines and under categories of medicines that share an effect. Repotrectinib is named in, or belongs to, 2 of them, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 2

Fo-ti With Hepatotoxic Drugs

Why this applies to Repotrectinib

  1. The SupplementFo-ti
  2. Interacts With the CategoryHepatotoxic Drugs
  3. Which IncludesRepotrectinib

We sort drugs into categories. Repotrectinib is in our Hepatotoxic Drugs category, and Fo-ti interacts with every drug in it, so this interaction applies to Repotrectinib.

Interaction Details Explained

Theoretically, fo-ti might increase the risk of liver damage when taken with hepatotoxic drugs.
Fo-ti has been linked to liver damage in many reports.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on reports of single cases, not a controlled study.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Fo-ti + Hepatotoxic Drugs Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the concern with pairing Fo-ti and Repotrectinib (Augtyro). This isn't about one changing the blood level of the other. Instead, both can be tough on the liver. Repotrectinib, like many targeted cancer drugs, can raise liver enzymes on its own, and your oncology team already watches your labs closely for that. Fo-ti has been tied to liver injury in a number of case reports, so adding it could stack an extra burden on the same organ.

To be fair, this is a theoretical, anecdotal concern rather than something proven in studies. Still, since your cancer treatment matters and liver safety is real, please don't add Fo-ti without first checking with your oncologist or pharmacist. Watch for yellowing skin or eyes, dark urine, belly pain, or unusual tiredness.

Still have a question about this interaction?

Contact Dr. Brian directly

References 13 sources behind this record

  1. Park GJ, Mann SP, Ngu MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol 2001;16:115-7.
  2. But PP, Tomlinson B, Lee KL. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. Vet Hum Toxicol 1996;38:280-2.
  3. UK Medicines and Healthcare Products Regulatory Agency. Polygonum multiflorum and liver reactions. April 2006. Available at: www.mhra.gov.uk/home/idcplg?IdcService= SS_GET_PAGE&useSecondary=true&ssDocName= CON2023590&ssTargetNodeId= 833 (Accessed 10 May 2
  4. Panis B, Wong DR, Hooymans PM, De Smet PA, Rosias PP. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J Pediatr Gastroenterol Nutr 2005;41:256-8. PubMed
  5. Mazzanti G, Battinelli L, Daniele C, et al. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann Intern Med 2004;140:E589-90.
  6. Cardenas A, Restrepo JC, Sierra F, Correa G. Acute hepatitis due to shen-min: a herbal product derived from Polygonum multiflorum. J Clin Gastroenterol 2006;40:629-32. PubMed
  7. Laird AR, Ramchandani N, deGoma EM, et al. Acute hepatitis associated with the use of an herbal supplement (Polygonum multiflorum) mimicking iron-overload syndrome. J Clin Gastroenterol 2008;42:861-2. PubMed
  8. Jung KA, Min HJ, Yoo SS, et al. Drug-Induced Liver Injury: Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum Thunb. Gut Liver 2011;5(4):493-9. PubMed
  9. Yuen, M. F., Tam, S., Fung, J., Wong, D. K., Wong, B. C., and Lai, C. L. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment.Pharmacol.Ther 10-15-2006;24(8):1179-1186. PubMed
  10. Bae, S. H., Kim, D. H., Bae, Y. S., Lee, K. J., Kim, D. W., Yoon, J. B., Hong, J. H., and Kim, S. H. [Toxic hepatitis associated with Polygoni multiflori]. Korean J.Hepatol. 2010;16(2):182-186. PubMed
  11. Furukawa, M., Kasajima, S., Nakamura, Y., Shouzushima, M., Nagatani, N., Takinishi, A., Taguchi, A., Fujita, M., Niimi, A., Misaka, R., and Nagahara, H. Toxic hepatitis induced by show-wu-pian, a Chinese herbal preparation. Intern.Med. 2010;49(15):1537-1 PubMed
  12. Dong H, Slain D, Cheng J, Ma W, Liang W. Eighteen cases of liver injury following ingestion of Polygonum multiflorum. Complement Ther Med 2014;22(1):70-4. PubMed
  13. Lei X, Chen J, Ren J, et al. Liver damage associated with Polygonum multiflorum Thunb.: a systematic review of case reports and case series. Evid Based Complement Alternat Med 2015;2015:459749.
Moderate Interaction 2 of 2

Fo-ti With Cytochrome P450 3A4 (CYP3A4) Substrates

Repotrectinib is also in our Cytochrome P450 3A4 (CYP3A4) Substrates category.

Interaction Details Explained

Theoretically, fo-ti might increase the levels and clinical effects of drugs metabolized by CYP3A4.
In vitro research suggests that fo-ti might inhibit CYP3A4. One in vitro study suggests that the degree of CYP3A4 inhibition may depend on the type of fo-ti extract (i.e., the raw plant leads to greater inhibition than extensively processed extracts). However, this evidence conflicts with animal research suggesting that fo-ti does not inhibit CYP3A4. This interaction has not been reported in humans.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Fo-ti + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Repotrectinib (Augtyro) is a cancer medication that your body clears using a liver enzyme called CYP3A4. The concern here is that fo-ti may slow that enzyme down. If it does, your body could remove Repotrectinib more slowly, letting levels creep up. That may mean more of this drug's known side effects, such as dizziness, numbness or tingling, muscle weakness, fatigue, or changes in heart rhythm.

I want to be honest about the strength of this: it is only theoretical, based on lab studies, and it has not been seen in people. Some research even suggests fo-ti may not affect this enzyme at all. Still, because this is a serious cancer therapy, please check with your oncology team or pharmacist before combining the two.

Still have a question about this interaction?

Contact Dr. Brian directly

References 3 sources behind this record

  1. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
  2. Zhang Y, Ding T, Diao T, Deng M, Chen S. Effects of Polygonum multiflorum on the activity of cytochrome P450 isoforms in rats. Pharmazie 2015;70(1):47-54. DOI
  3. Xing Y, Yu Q, Zhou L, et al. Cytochrome P450-mediated herb-drug interaction (HDI) of Polygonum multiflorum Thunb. based on pharmacokinetic studies and in vitro inhibition assays. Phytomedicine 2023;112:154710. PubMed
Know someone taking this combination? Share

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Fo-ti Also Interacts With Other Medications

Besides Repotrectinib, Fo-ti has 1,258 moderate known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Fo-ti

Covers the 2,830 medications we’ve checked against Fo-ti. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Repotrectinib

Take other supplements too? 190 supplements have a documented interaction with Repotrectinib, each explained on its page.

By severity: 6 major, 146 moderate and 38 minor.

The Most Serious There Right Now:

Open the Repotrectinib interaction pageEvery supplement checked against Repotrectinib, ranked by severity
One More Smart Check

Taking Fo-ti as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Fo-ti. We have broken down 976 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Repotrectinib:

Fo-ti Products People Look Up

Get to Know Each One

About Fo-ti and Repotrectinib

Supplement

About Fo-ti

Fo-ti (He Shou Wu) is a root used in traditional Chinese medicine, often promoted for healthy aging and hair. High-quality human evidence for these benefits is limited, and processed Fo-ti has been linked to reports of liver injury, so caution and professional guidance are important.

Full Fo-ti guide: uses, dosage, safety and every interaction
Medication

About Repotrectinib

Brand name: Augtyro

Repotrectinib, sold as Augtyro capsules, treats certain cancers driven by specific gene changes. Your tumor must test positive for the gene change.

Repotrectinib: uses, dosage and side effects Repotrectinib: interactions with other drugs Taking more than these two? Check Fo-ti and Repotrectinib with everything else you take Repotrectinib NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Fo-ti and Repotrectinib

Other drugs in the category this interaction applies to, and other supplements people check with Repotrectinib.

Moderate

Also in Our Hepatotoxic Drugs Category

Fo-ti interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

355 more in this category are on the Fo-ti interactions list.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Fo-ti interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

384 more in this category are on the Fo-ti interactions list.

Other Supplements With Repotrectinib

The most serious documented interactions with Repotrectinib first, then supplements with none on record, the most looked-up leading.

Show all 25 supplementsShow fewer
Keep Checking

Other Drugs & Fo-ti

Browse every other medication we’ve checked against Fo-ti — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
1,258Moderate
0Minor
1,571No known interaction
Moderate

Moderate: 1,258 interactions

Showing 60 of 1,258 moderate interactions — see all 1,258 on the Fo-ti page.

No Interaction 1,571 drugs checked — show the list
How Much People Look This Up

Where Fo-ti and Repotrectinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Fo-ti
Top 25%

#159 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Repotrectinib
Steady interest

#2,025 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Fo-ti and Repotrectinib Together: Common Questions

Can you take Fo-ti with Repotrectinib?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Fo-ti with Augtyro?
Augtyro is a brand name of repotrectinib, so the answer is the same as for repotrectinib. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Augtyro too.
Why are there 2 interaction records for Fo-ti and Repotrectinib?
We file interactions under single medicines and under categories of medicines that share an effect. Repotrectinib is named in, or belongs to, 2 of the categories we list for Fo-ti, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Fo-ti and Repotrectinib interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Fo-ti and Repotrectinib?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.